Aspirin therapy should be first-line treatment in secondary prevention of stroke - Against

Stroke

Volumn 33, Issue 8, 2002, Pages 2138-2139

  Diener, Hans Christoph ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Aspirin; Clopidogrel; Dipyridamole; Stroke prevention; Ticlopidine

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; DIPYRIDAMOLE; TICLOPIDINE;

DISEASE ASSOCIATION; DOSE RESPONSE; HEART INFARCTION; HUMAN; PRIORITY JOURNAL; PROPHYLAXIS; RISK FACTOR; SECONDARY PREVENTION; SHORT SURVEY; STROKE; TRANSIENT ISCHEMIC ATTACK; TREATMENT PLANNING;

ASPIRIN; CARDIOVASCULAR DISEASES; CEREBROVASCULAR ACCIDENT; DIPYRIDAMOLE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; HUMANS; ISCHEMIC ATTACK, TRANSIENT; MULTICENTER STUDIES; PLATELET AGGREGATION INHIBITORS; RANDOMIZED CONTROLLED TRIALS; RISK; TICLOPIDINE; TREATMENT OUTCOME;

EID: 0036328005     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000023102.03179.30     Document Type: Short Survey

References (8)

1. Short-term prognosis after emergency department diagnosis of TIA
2. Collaborative overview of randomised trials of antiplatelet therapy, I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients
3. A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke
4. The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke
5. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)
6. European Stroke Prevention Study 2: Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke
7. The European Stroke Prevention Study (ESPS): Principal end-points
8. European Stroke Prevention Study 2: Efficacy and safety data